Multi-Drug Therapy Including Immune Checkpoint Inhibitors in Ovarian Cancer
Received Date: Dec 20, 2019 / Accepted Date: Jan 06, 2020 / Published Date: Jan 13, 2020
Ovarian cancer has the worst prognosis among gynecological cancers. Since only a few cases of ovarian cancer could be treated effectively with immune checkpoint inhibitor monotherapy, to improve the prognosis of ovarian cancer, multi-drug therapy including immune checkpoint inhibitors is necessary. In this short commentary, we highlight the need for studies on novel treatment strategies.
Keywords: Microsatellite instability; Ovarian cancer; Immune checkpoint inhibitor; Immunohistochemistry; Mismatch repair protein
Citation: Yamashita H, Nakayama K, Kyo S (2019) Multi-Drug Therapy Including Immune Checkpoint Inhibitors in Ovarian Cancer. Diagn Pathol Open 4: 159.
Copyright: © 2020 Yamashita H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
- Total views: 105
- [From(publication date): 0-0 - Apr 02, 2020]
- Breakdown by view type
- HTML page views: 86
- PDF downloads: 19